-
Mashup Score: 6Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients - 5 hour(s) ago
A Newcastle disease virus engineered to enhance anti-tumor immune responses provided a 90% rate of disease control in a clinical trial of 20 patients with diverse refractory cancer types and with distant metastases.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7
Don’t forget the power of a strong doctor-patient relationship
Source: www.medpagetoday.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Uremic Pruritus; Its Prevalence, Pathophysiology and Management - 22 day(s) ago
Open access peer-reviewed chapter
Source: www.intechopen.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release - PubMed - 22 day(s) ago
We have studied the role of interleukin-2 (IL-2) and its receptors in the impaired in vitro lymphocyte response characteristic of hemodialysis patients treated by means of cuprophane membranes. The proliferative response of T lymphocytes as well as T-cell-dependent B cell proliferation after stimula …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Targeting the Opioid Pathway for Uremic Pruritus: A Systematic Review and Meta-analysis - 22 day(s) ago
Patients undergoing hemodialysis or peritoneal dialysis often experience pruritus which is associated with morbidity and mortality. One proposed treatment approach is to target the opioid pathway using either µ-opioid antagonists or κ-opioid …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
Official websites use .gov A.gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Increased plasma histamine levels in uraemic pruritus - PubMed - 22 day(s) ago
1. We determined plasma levels of histamine in uraemic patients and examined their correlation with the presence of pruritus. 2. In 27 patients with chronic renal failure, plasma histamine levels were analysed by radioimmunoassay and were compared with those of 40 healthy adult subjects. The control …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Pruritus in hemodialysis patients - 22 day(s) ago
Pruritus is one of the most bothersome symptoms in patients on maintenance hemodialysis (HD), however little progress is seen in our understanding of its pathogenesis. The aim of this study was to evaluate the frequency of pruritus in HD patients in …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5
The problem of pruritus in uremic dialysed patients remains unsolved. The etiology of pruritus has not been precisely explained, and sometimes no efficient treatment is available. The aim of this study was to analyse the relationship between somatic neuropathy and pruritus as well as the relationshi …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
Crazy cool study investigating alpha-gal gene therapy for refractory solid cancers (leading the immune system to ‘reject’ the cancer like an organ transplant) https://t.co/moVNMUluAL https://t.co/LmU6h0Shcd